ABSTRACT Triple‐negative breast cancer (TNBC) is a highly aggressive and lethal malignancy with poor response to conventional therapeutic regimens. Thus, there is an urgent need to
This is a narrative review synthesizing mechanistic and preclinical evidence on peptide self-assembly platforms for triggering immunogenic cell death pathways; it raises theoretical frameworks and design principles rather than reporting empirical clinical outcomes.